To validate the association of PD-L1CON expression with active IFN and TNF signalling, and reduced differentiation and oxidative phosphorylation expression signatures in melanoma tumours, we used the SKCM TCGA dataset consisting of 458 melanoma tumour samples. The gene discussed is IFNA1; the disease is melanoma.